{Reference Type}: Journal Article
{Title}: Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli.
{Author}: Naveed A;Yu J;Lawson S;Gao R;Ni S;Paulchakrabarti M;Choudhury B;Christopher-Hennings J;Nelson E;Sheng Z;Kennedy MA;Li F;Wang D;
{Journal}: Virology
{Volume}: 597
{Issue}: 0
{Year}: 2024 Sep 12
{Factor}: 3.513
{DOI}: 10.1016/j.virol.2024.110138
{Abstract}: The hemagglutinin-esterase-fusion (HEF) protein binds 9-O-acetylated sialic acids-containing glycans on the cell surface and drives influenza D virus (IDV) entry. The HEF is a primary determinant of the exceptional thermal and acid stability observed in IDV infection biology. Here, we expressed and purified the receptor binding domain (RBD) of the IDV HEF protein in Escherichia coli and characterized its receptor binding and antigenic properties. The data from these experiments indicate that (i) the RBD can bind with specificity to turkey red blood cells (RBC), and its binding can be specifically inhibited by IDV antibody; (ii) the RBD efficiently binds to the cell surface of MDCK cells expressing the receptor of IDV; and (iii) anti-RBD antibodies are capable of blocking RBD attachment to MDCK cells as well as of inhibiting the virus from agglutinating RBCs. These observations support the utility of this RBD in future receptor and entry studies of IDV.